Technology
Health
Pharmaceutical
Avenue Therapeutics
$5.999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.03 (-0.50%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ATXI and other stocks, options, ETFs, and crypto commission-free!
About ATXI
Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. Read More The company was founded on February 9, 2015 and is headquartered in New York, NY.
CEO
Employees
6
Headquarters
New York, New York
Founded
2015
Market Cap
100.17M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
19.21K
High Today
$6.11
Low Today
$5.80
Open Price
$6.00
Volume
10.05K
52 Week High
$7.98
52 Week Low
$2.08
Collections
Technology
Health
Pharmaceutical
Therapy
2017 IPO
US
North America
Female CEOs
Price Paid on Robinhood
14% Higher
Right Now
52 Week Low
$2.08
Average Price Paid
$5.27
52 Week High
$6.82
ATXI Earnings
-$1.03
-$0.77
-$0.51
-$0.25
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 13, Pre-Market